CFA
GILD icon

CT Financial Advisors’s Gilead Sciences GILD Stock Holding History

CT Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$86.7K Sell
1,277
-623
-33% -$43.8K 0.05% 214
2016
Q4 		$136K Buy
1,900
+100
+6% +$7.43K 0.09% 172
2016
Q3 		$142K Buy
1,800
+1,200
+200% +$97.5K 0.09% 170
2016
Q2 		$50.1K Sell
600
-400
-40% -$35.5K 0.03% 264
2016
Q1 		$91.9K Buy
1,000
+150
+18% +$13.5K 0.05% 214
2015
Q4 		$86K Hold
850
– – 0.05% 226
2015
Q3 		$83.5K Buy
850
+100
+13% +$11.1K 0.05% 232
2015
Q2 		$87.8K Buy
+750
New +$82K 0.05% 237

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

CT Financial Advisors's GILD Position: Q1 2017 in Review

CT Financial Advisors reduced its Gilead Sciences (GILD) stake by 33% in Q1 2017, selling an estimated $43.8K and leaving 1,277 shares worth $86.7K. The position accounts for 0.05% of the portfolio, ranked #214.

CT Financial Advisors first reported a position in GILD in Q2 2015 and has held it in 8 quarters since. The position peaked at $142K in Q3 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • CT Financial Advisors held 1,277 shares of Gilead Sciences worth $86.7K as of Q1 2017.
  • CT Financial Advisors sold 623 Gilead Sciences shares in Q1 2017, an estimated $43.8K.
  • Gilead Sciences made up 0.05% of CT Financial Advisors's portfolio in Q1 2017, its #214 holding.
  • CT Financial Advisors first reported a position in Gilead Sciences in Q2 2015 and has held it in 8 quarters since.
  • CT Financial Advisors's Gilead Sciences position peaked at $142K in Q3 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.